Filtros de búsqueda

Lista de obras de Jessika Bertacchini

A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward

scientific article published on September 2009

An interaction study in mammalian cells demonstrates weak binding of HSPB2 to BAG3, which is regulated by HSPB3 and abrogated by HSPB8.

artículo científico publicado en 2017

Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit

artículo científico publicado en 2018

Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis.

artículo científico publicado en 2014

Inhibition of Ras-mediated signaling pathways in CML stem cells.

artículo científico publicado en 2015

Lamin A Ser404 is a nuclear target of Akt phosphorylation in C2C12 cells

artículo científico publicado en 2008

Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression

artículo científico publicado en 2009

Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.

artículo científico publicado en 2007

Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro.

artículo científico publicado en 2017

Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.

artículo científico publicado en 2015

Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia

artículo científico publicado en 2010

Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.

artículo científico publicado en 2015

Targeting PI3K/AKT/mTOR network for treatment of leukemia.

artículo científico publicado en 2015

The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda